Antibody-mediated neutralization of authentic SARS-CoV-2 B.1.617 variants harboring L452R and T478K/E484Q

Alexander Wilhelm, Tuna Toptan, Christiane Pallas, Timo Wolf, Udo Goetsch, Rene Gottschalk, Maria JGT Vehreschild, Sandra Ciesek, Marek Widera
doi: https://doi.org/10.1101/2021.08.09.21261704

Article usage

Article usage: August 2021 to November 2024

AbstractFullPdf
Aug 2021209924414
Sep 20213125952
Oct 20213612121
Nov 20213251231
Dec 2021364655
Jan 2022200514
Feb 202299113
Mar 2022241310
Apr 202225039
May 2022456217
Jun 20224618
Jul 20223216
Aug 20222724
Sep 202210617
Oct 202242510
Nov 20223337
Dec 20222434
Jan 20232315
Feb 20234756
Mar 20234530
Apr 202333211
May 20231618
Jun 20231552
Jul 202327110
Aug 202335107
Sep 20233046
Oct 20232611
Nov 202328218
Dec 20231943
Jan 2024704
Feb 20241934
Mar 20241686
Apr 20241084
May 20241238
Jun 202422510
Jul 20241759
Aug 20241536
Sep 2024321113
Oct 2024101010
Nov 2024133
Back to top
Posted August 12, 2021.
Download PDF
Data/Code
Email
Antibody-mediated neutralization of authentic SARS-CoV-2 B.1.617 variants harboring L452R and T478K/E484Q
Alexander Wilhelm, Tuna Toptan, Christiane Pallas, Timo Wolf, Udo Goetsch, Rene Gottschalk, Maria JGT Vehreschild, Sandra Ciesek, Marek Widera
medRxiv 2021.08.09.21261704; doi: https://doi.org/10.1101/2021.08.09.21261704
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area